Aralez Bio is the leader in enzymatic synthesis of novel amino acids. Our noncanonical amino acids (ncAAs) can be made with unprecedented chemical diversity - we can pinpoint placement of functional groups around an aromatic ring leaving highly pure, chiral compounds. We can produce ncAAs at clinical supply scales. Our enzymatic platform is based on traditional biotechnology resulting in ncAAs that are lower in cost with predictable delivery times for you.
Our pipeline of ncAAs is growing exponentially. Applications for our chiral building blocks span across drug discovery and development modalities: peptides, macrocycles, drug conjugates, and protein degraders. We are looking for partners to facilitate development of specialized, therapeutically-interesting ncAAs and would like to meet with you to discuss possible collaborations. Please get in touch by filling out the form below or emailing contact@aralezbio.com
As our technology develops, we continue to unlock access to additional novel chemical design space. We'd like to partner with you or form an alliance to collaboratively grow our companies. Please let us know what your needs are.
